Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone effects on dabigatran and rivaroxaban concentrations in atrial fibrillation
ChiCTR2200062928Phase 4Not yet recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dronedarone, dabigatran, rivaroxaban and amiodarone in Atrial fibrillation (AFib) (6 arms), sponsored by First Hospital of China Medical University. Primary endpoint: Peak and trough plasma concentrations of dabigatran and rivaroxaban. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
dronedaronedabigatranrivaroxabanamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2200062928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062928.